Goldman Sachs maintains its Buy rating and 2011-12 EPS estimates on Health Net HNT after HNT announced its first-time 2011 revenue and earnings guidance.
HNT expects EPS to be "at least $2.75" vs. Goldman Sachs' estimate of $2.90 and Street consensus of $2.80. Revenue is expected to be $12.0-$12.5 bn vs. GS' estimate of $11.7 bn, and the Street's consensus of $13.7 bn.
Goldman Sachs maintains its $32 price target.
HNT is trading at $26.88.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsGoldman SachsHealth CareHealth NetManaged Health Care
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in